Intrapleural Tenecteplase Therapy in Treatment of Loculated Parapneumonic Pleural Effusions and Empyema

Background: Thoracic empyema (TE) and loculated parapneumonic effusions (CPE) cause considerable morbidity and mortality, with an estimated case-fatality rate of 15%. Intrapleural administration of recombinant tissue plasminogen activators (r-TPA) such as tenecteplase (TNKase) has been recently empl...

Full description

Bibliographic Details
Main Authors: Alaa Refaat, Nasr Affara, Tark Muhsen, Moataz Salahuddin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-10-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0422763814001526

Similar Items